Revenue | ₹0.09Cr |
Net Profits | ₹0.02Cr |
Net Profit Margins | 22.22% |
Genomic Valley Biotech Ltd’s revenue fell -43.75% since last year same period to ₹0.09Cr in the Q1 2025-2026. On a quarterly growth basis, Genomic Valley Biotech Ltd has generated -65.38% fall in its revenue since last 3-months.
Genomic Valley Biotech Ltd’s net profit fell -84.62% since last year same period to ₹0.02Cr in the Q1 2025-2026. On a quarterly growth basis, Genomic Valley Biotech Ltd has generated 125% jump in its net profits since last 3-months.
Genomic Valley Biotech Ltd’s net profit margin fell -72.65% since last year same period to 22.22% in the Q1 2025-2026. On a quarterly growth basis, Genomic Valley Biotech Ltd has generated 172.22% jumped in its net profit margins since last 3-months.
The revenue for Genomic Valley Biotech Ltd in the Q1 results 2025 was ₹0.09Cr.
The net profit for Genomic Valley Biotech Ltd in the Q1 results 2025 was ₹0.02Cr.
The net profit margin for Genomic Valley Biotech Ltd in the Q1 results 2025 was 22.22%.
The revenue for Genomic Valley Biotech Ltd in the Q1 results 2024 was ₹0.16Cr.
The net profit for Genomic Valley Biotech Ltd in the Q1 results 2024 was ₹0.13Cr.
The net profit margin for Genomic Valley Biotech Ltd in the Q1 results 2024 was 81.25%.